1. Home
  2. DWSN vs NTHI Comparison

DWSN vs NTHI Comparison

Compare DWSN & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$3.29

Market Cap

130.4M

Sector

Energy

ML Signal

HOLD

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.24

Market Cap

114.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
NTHI
Founded
1952
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
130.4M
114.6M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
DWSN
NTHI
Price
$3.29
$4.24
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
124.0K
150.4K
Earning Date
05-12-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
53.85
N/A
EPS
0.25
N/A
Revenue
$145,773,000.00
$39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$3.01
52 Week High
$7.85
$12.99

Technical Indicators

Market Signals
Indicator
DWSN
NTHI
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
DWSN
NTHI

About DWSN Dawson Geophysical Company

Dawson Geophysical Co provides seismic data acquisition services mainly to providers of multi-client data libraries and directly to onshore oil and natural gas exploration and development companies in the continental U.S. and Canada. The demand for seismic services is largely influenced by drilling and completion activity, exploration budgets, and prevailing and anticipated crude oil and natural gas prices. Its data acquisition crews serve companies engaged in the exploration and development of oil and gas on land and in land-to-water transition areas. The business operates through two reportable segments, with U.S. operations generating the majority of revenue and Canada operations contributing additionally.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: